• Christie Brinkley partners with Merz

    During her 45-year span in the beauty and fashion industries, Christie Brinkley has maintained her youthful appearance. Through her partnership with Merz, Ms. Brinkley shares why she chose to be treated with Botulinum Toxin and Ultherapy® to remain looking timeless and natural at age 63.

    Learn more about the non-surgical lift that's making beautiful changes arround the world.

    Read more

  • Dedicated to the development of neurotoxin therapy

    For patients with movement disorders, botulinum neurotoxin is often the treatment of choice. Merz´s expertise in this area has produced the only botulinum neurotoxin free from complexing proteins.

    Read more

    We are constantly working to advance new treatment standards and improve the quality of research, education and patient care.

    Read more

  • Celebrating 110 years of Merz

    110 years ago, on March 9, 1918, the pharmacist and chemist Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, Merz remains a family-owned company, but has evolved into a global leader in aesthetic medicine and neurotoxin therapy.

    Read more

    The motto of Friedrich Merz, who was born in 1884 in the town of Groß-Bieberau in the German Odenwald mountain range, was: “Trust yourself, be different, and invent products that are truly needed.“

    Read more

  • Careers at Merz

    As a family-owned company, we offers our employees a high level of support and stability, along with the added benefits of a truly international presence and global perspective.

    Read more

    At Merz, you will find aligned values, passionate people, enriching relationships and limitless possibilities – come join us!

    Read more

We envision new ways to improve the lives of our patients all over the world.

News

Xeomin® (incobotulinumtoxinA) Receives European Approval for Treatment of Chronic Sialorrhea in Adults

Frankfurt, Germany /

First and only botulinum neurotoxin approved for this indication in Europe Merz, a global leader in neurotoxin therapy, announced today the European approval of Xeomin® (incobotulinumtoxinA) for the symptomatic treatment…

Read more

HRA Pharma To Acquire the Mederma® Brand from Merz

Frankfurt, Germany / Paris, France /

Merz, a global leader in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, a fast-growing, innovative global consumer healthcare company, announced today that they have signed an asset purchase agreement,…

Read more

Merz Launches New Belotero® Revive Dermal Filler

Frankfurt, Germany /

The new hyaluronic acid (HA) filler works beneath the skin to improve skin hydration, reduce redness and roughness and minimize the appearance of fine lines. Merz, a global leader in…

Read more

Contact Us

If you would like to submit a speculative application or apply for an open position, please make sure
to use only our job portal, which you can find at the following link:
https://www.merz.com/career/direct-entry/
Please note that we cannot consider your application if you send it via any other channel.

* mandatory fields

Please note that if you submit information to Merz all materials submitted by electronic or physical communication will be deemed non-confidential. Do not submit any information or other materials that you consider to be confidential or proprietary. While we have no intention to publicly disclose any details of your proposal, we may refer to select experts within or outside the Merz network for evaluation.